News
6don MSN
Trump, pharma industry discuss boosting medicine spending abroad to cut US prices, sources say
Drugmakers generate most of their sales in the U.S. The Pharmaceutical Research and Manufacturers of America - the industry's ...
To navigate the post-LDC era successfully, Bangladesh must transition from a volume-driven, generics-dominated model to one ...
The announcement by President Donald Trump's administration of the results of a probe into pharmaceutical imports and new ...
Despite current headwinds like tariffs and patent expirations, I see long-term opportunity in top-tier pharmaceutical stocks ...
India and China are set to discuss a trade package focusing on essential commodities like rare earth magnets, fertilizers, ...
Commerce Secretary Howard Lutnick originally stated the investigation should be completed by mid-June. However, a new report from Reuters says that any official announcement on tariffs is still weeks ...
A closer look at the top biotechnology and pharmaceutical companies in the 2025 IndustryWeek 500. The pharmaceutical industry ...
Learn more about whether Amneal Pharmaceuticals, Inc. or Liquidia Corporation is a better investment based on AAII's A+ ...
The Q2 pharma earnings season featured changes in the obesity race as well as insights into drugmakers’ views on tariffs and drug pricing.
No additional tariffs have been imposed on Indian exports to the United States in key sectors such as pharmaceuticals and ...
The pharmaceutical industry is on high alert as US President Donald Trump proposes a 200%-250% tariff on drug imports, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results